These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 31671446)

  • 61. Effect of a serogroup A meningococcal conjugate vaccine (PsA-TT) on serogroup A meningococcal meningitis and carriage in Chad: a community study [corrected].
    Daugla DM; Gami JP; Gamougam K; Naibei N; Mbainadji L; Narbé M; Toralta J; Kodbesse B; Ngadoua C; Coldiron ME; Fermon F; Page AL; Djingarey MH; Hugonnet S; Harrison OB; Rebbetts LS; Tekletsion Y; Watkins ER; Hill D; Caugant DA; Chandramohan D; Hassan-King M; Manigart O; Nascimento M; Woukeu A; Trotter C; Stuart JM; Maiden M; Greenwood BM
    Lancet; 2014 Jan; 383(9911):40-47. PubMed ID: 24035220
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Modeling Long-term Vaccination Strategies With MenAfriVac in the African Meningitis Belt.
    Karachaliou A; Conlan AJ; Preziosi MP; Trotter CL
    Clin Infect Dis; 2015 Nov; 61 Suppl 5(Suppl 5):S594-600. PubMed ID: 26553693
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Epidemics of meningococcal meningitis in Northern Nigeria focus on preventive measures.
    Balarabe SA
    Ann Afr Med; 2018; 17(4):163-167. PubMed ID: 30588927
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Emergence and control of epidemic meningococcal meningitis in sub-Saharan Africa.
    Mohammed I; Iliyasu G; Habib AG
    Pathog Glob Health; 2017 Feb; 111(1):1-6. PubMed ID: 28081671
    [TBL] [Abstract][Full Text] [Related]  

  • 65. The threat of meningococcal disease during the Hajj and Umrah mass gatherings: A comprehensive review.
    Yezli S
    Travel Med Infect Dis; 2018; 24():51-58. PubMed ID: 29751133
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Risk of epidemic meningitis in Africa: a cause for concern.
    Wkly Epidemiol Rec; 2007 Mar; 82(10):79-87. PubMed ID: 17348094
    [No Abstract]   [Full Text] [Related]  

  • 67. From Epidemic Meningitis Vaccines for Africa to the Meningitis Vaccine Project.
    Aguado MT; Jodar L; Granoff D; Rabinovich R; Ceccarini C; Perkin GW
    Clin Infect Dis; 2015 Nov; 61 Suppl 5(Suppl 5):S391-5. PubMed ID: 26553665
    [TBL] [Abstract][Full Text] [Related]  

  • 68. The Changing Epidemiology of Meningococcal Disease.
    Cohn A; MacNeil J
    Infect Dis Clin North Am; 2015 Dec; 29(4):667-77. PubMed ID: 26610420
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Epidemiologic investigation and targeted vaccination initiative in response to an outbreak of meningococcal disease among illicit drug users in Brooklyn, New York.
    Weiss D; Stern EJ; Zimmerman C; Bregman B; Yeung A; Das D; Dentinger CM; Marx MA; Kornblum J; Lee L; Halse TA; Mayer LW; Hatcher CP; Theodore MJ; Schmink S; Harcourt BH; Zucker JR; Layton M; Clark TA;
    Clin Infect Dis; 2009 Apr; 48(7):894-901. PubMed ID: 19231975
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Impact of serogroup A meningococcal conjugate vaccine for Africa.
    Stuart JM
    Hum Vaccin Immunother; 2018 May; 14(5):1116-1117. PubMed ID: 29194010
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Exploring the population-level impact of MenB vaccination via modeling: Potential for serogroup replacement.
    Hogea C; Van Effelterre T; Vyse A
    Hum Vaccin Immunother; 2016; 12(2):451-66. PubMed ID: 26308796
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Meningitis control in countries of the African meningitis belt, 2015.
    Wkly Epidemiol Rec; 2016 Apr; 91(16):209-16. PubMed ID: 27108455
    [No Abstract]   [Full Text] [Related]  

  • 73. [An epidemic of meningococcal meningitis in the region of Savanes in Togo in 1997: research and control strategies].
    Aplogan A; Batchassi E; Yakoua Y; Croisier A; Aleki A; Schlumberger M; Molina S; Sidatt M; Kaninda AV
    Sante; 1997; 7(6):384-90. PubMed ID: 9503496
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Impact of vaccination during an epidemic of serogroup C meningococcal disease in Salvador, Brazil.
    Cardoso CW; Pinto LL; Reis MG; Flannery B; Reis JN
    Vaccine; 2012 Aug; 30(37):5541-6. PubMed ID: 22749604
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Eliminating Meningococcal Epidemics From the African Meningitis Belt: The Case for Advanced Prevention and Control Using Next-Generation Meningococcal Conjugate Vaccines.
    Alderson MR; LaForce FM; Sobanjo-Ter Meulen A; Hwang A; Preziosi MP; Klugman KP
    J Infect Dis; 2019 Oct; 220(220 Suppl 4):S274-S278. PubMed ID: 31671447
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Nigeria battles infection on several fronts.
    Bagcchi S
    Lancet Infect Dis; 2017 Aug; 17(8):808-809. PubMed ID: 28741548
    [No Abstract]   [Full Text] [Related]  

  • 77. [Epidemiological notes: meningococcal meningitis of serogroup X in Niamey (Niger)].
    Etienne J; Sperber G; Adamou A; Picq JJ
    Med Trop (Mars); 1990 Apr; 50(2):227-9. PubMed ID: 2117224
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Patterns of meningococcal infection in Sudan with emergence of Neisseria meningitidis serogroup W135.
    Karsany MS; Elshayeb AA; Saeed ES; Elaagib R; Ibrahim SA; Elsamani E; Hussien K; Salih KM
    East Mediterr Health J; 2013 Oct; 19(10):843-6. PubMed ID: 24313147
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Meningococcal serogroup W135 in the African meningitis belt: epidemiology, immunity and vaccines.
    Mueller JE; Borrow R; Gessner BD
    Expert Rev Vaccines; 2006 Jun; 5(3):319-36. PubMed ID: 16827617
    [TBL] [Abstract][Full Text] [Related]  

  • 80. [Paediatric meningococcal meningitis in France: ACTIV/GPIP network results].
    Levy C; Taha MK; Bingen E; Cohen R;
    Arch Pediatr; 2012 Sep; 19 Suppl 2():S49-54. PubMed ID: 22883366
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.